Search
Search results
179 results found
Treatment optimization of subcutaneous infliximab in patients with inflammatory bowel disease.
Gade, Ajay, Alessandra Saraga, Tina Deyhim, Grace Geeganage, Adam S Cheifetz, and Konstantinos Papamichael. 2025. “Treatment Optimization of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease.”. Expert Review of Gastroenterology & Hepatology.
Center for Inflammatory Bowel Disease
The Center for Inflammatory Bowel Disease at BIDMC — Where Patient Needs Meet World-Class IBD Care. We provide comprehensive, multidisciplinary care and advance research to improve the lives of those with Crohn’s disease and ulcerative colitis.
Antisense to human CD39 dysregulates immune metabolism in inflammatory bowel disease.
Zhang, Lina, Cortney Cagle, Du Hanh Nguyen, Graziela Scheuer Gomes, Barbora Gromova, Eva Csizmadia, Arian Karimitar, et al. 2025. “Antisense to Human CD39 Dysregulates Immune Metabolism in Inflammatory Bowel Disease.”. Cellular & Molecular Immunology 22 (7): 730-42.
Medical management of acute severe ulcerative colitis in the hospitalized patient.
Rabinowitz, Loren G, Ajay Gade, and Joseph D Feuerstein. 2025. “Medical Management of Acute Severe Ulcerative Colitis in the Hospitalized Patient.”. Expert Review of Gastroenterology & Hepatology 19 (5): 467-80.
Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.
Shubow, Sophie, Michele Gunsior, Amy Rosenberg, Yow-Ming Wang, Tara Altepeter, Daphne Guinn, Mohsen Rajabiabhari, et al. 2025. “Therapeutic Drug Monitoring of Biologics: Current Practice, Challenges and Opportunities - a Workshop Report.”. The AAPS Journal 27 (2): 62.
A practical guide to dilating inflammatory bowel disease strictures.
Klemm, Natasha K, and Joseph D Feuerstein. 2025. “A Practical Guide to Dilating Inflammatory Bowel Disease Strictures.”. Expert Review of Gastroenterology & Hepatology 19 (4): 377-87.
Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.
Allegretti, Jessica R, Adam S Cheifetz, Parambir S Dulai, A C Stevens, Jillian Chapas-Reed, Laurent Chesnel, Bharat Dixit, et al. 2024. “Safety, Pharmacokinetics, and Clinical Efficacy of ADS051, a Neutrophil Modulator, in Ulcerative Colitis: Results of a Randomized Phase 1b Trial.”. The American Journal of Gastroenterology 120 (7): 1624-35.
Discriminazione Basata sul Genere-Barriers Persist for Women Gastroenterologists in Italy.
Sharma, Nivita D, and Loren G Rabinowitz. 2025. “Discriminazione Basata Sul Genere-Barriers Persist for Women Gastroenterologists in Italy.”. Digestive Diseases and Sciences 70 (1): 23-25.
Morning Salivary Cortisol Has a Positive Correlation with GAD-7 Scores in Patients with Ulcerative Colitis.
Castro, Cristina M, Aditya Mithal, Tina Deyhim, Loren G Rabinowitz, Olawande Olagoke, Steven D Freedman, Adam S Cheifetz, Sarah K Ballou, and Konstantinos Papamichael. 2024. “Morning Salivary Cortisol Has a Positive Correlation With GAD-7 Scores in Patients With Ulcerative Colitis.”. Journal of Clinical Medicine 13 (22).